EC Number |
Title |
Organism |
---|
3.4.24.B15 | Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia Novel mutations in PHEX and SLC34A3 |
Homo sapiens |
3.4.24.B15 | Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma |
Homo sapiens |
3.4.24.B15 | Functional analysis of 22 splice-site mutations in the PHEX, the causative gene in X-linked dominant hypophosphatemic rickets |
Homo sapiens |
3.4.24.B15 | Whole exome sequencing reveals novel PHEX splice site mutations in patients with hypophosphatemic rickets |
Homo sapiens |
3.4.24.B15 | A novel Phex mutation in a new mouse model of hypophosphatemic rickets |
Mus musculus |
3.4.24.B15 | A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells |
Mus musculus |
3.4.24.B15 | Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia |
Mus musculus |
3.4.24.B15 | Analysis of recombinant Phex: an endopeptidase in search of a substrate |
Homo sapiens |
3.4.24.B15 | Analysis of recombinant Phex: an endopeptidase in search of a substrate |
Mus musculus |
3.4.24.B15 | ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate |
Mus musculus |